1. Home
  2. KBONU vs KLTOW Comparison

KBONU vs KLTOW Comparison

Compare KBONU & KLTOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

KBONU

Karbon Capital Partners Corp. Units

N/A

Current Price

$10.08

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Logo Klotho Neurosciences Inc. Warrant

KLTOW

Klotho Neurosciences Inc. Warrant

N/A

Current Price

$0.13

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KBONU
KLTOW
Founded
N/A
N/A
Country
United States
United States
Employees
N/A
3
Industry
Blank Checks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
2025
2022

Fundamental Metrics

Financial Performance
Metric
KBONU
KLTOW
Price
$10.08
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
N/A
N/A
Earning Date
N/A
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
N/A
N/A
52 Week High
N/A
N/A

Technical Indicators

Market Signals
Indicator
KBONU
KLTOW
Relative Strength Index (RSI) N/A 46.06
Support Level N/A $0.13
Resistance Level N/A $0.15
Average True Range (ATR) 0.00 0.01
MACD 0.00 0.00
Stochastic Oscillator 0.00 35.59

Price Performance

Historical Comparison
KBONU
KLTOW

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: